9,540 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Sava Infond d.o.o.

Sava Infond d.o.o. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 9,540 shares of the medical equipment provider’s stock, valued at approximately $4,979,000. Intuitive Surgical makes up about 0.9% of Sava Infond d.o.o.’s holdings, making the stock its 21st biggest holding.

Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the period. State Street Corp lifted its stake in Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. Geode Capital Management LLC lifted its stake in Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC grew its holdings in Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after purchasing an additional 86,488 shares during the period. Finally, Wellington Management Group LLP increased its position in Intuitive Surgical by 1.7% in the third quarter. Wellington Management Group LLP now owns 3,115,024 shares of the medical equipment provider’s stock worth $1,530,318,000 after buying an additional 53,383 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $509.03 on Thursday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market capitalization of $181.31 billion, a P/E ratio of 79.41, a P/E/G ratio of 5.85 and a beta of 1.43. The firm’s 50 day simple moving average is $559.82 and its 200 day simple moving average is $532.42.

Insider Activity

In related news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have recently weighed in on the company. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 17th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Leerink Partners lifted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target on the stock. Finally, JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $611.86.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.